Gevo (GEVO) is not currently a good stock to buy. Here's why:
- Financial Performance: Gevo has reported a net loss of $21 million and a total revenue of 5.26million,withadilutedEPSof-0.091. The company's financial performance indicates significant challenges.
GEVO Total Revenue, Net Income
- Growth Rates: Gevo's net income has decreased by -45.64%, while revenue has increased by 24.12%2. The decline in net income and negative EPS suggest that the company is struggling to maintain profitability.
GEVO Net Income YoY, Total Revenue YoY...
- Analyst Sentiments: Despite the poor financial performance, the consensus rating for Gevo is a 'Strong Buy' with an average price target of $143, indicating that some analysts see potential in the stock.
- Technical Indicators: Gevo's technical indicators are mixed. The RSI is overbought at 77.28, which could suggest that the stock is due for a pullback4. However, the stock is trading above its 5-Day, 10-Day, and 20-Day moving averages, which could indicate short-term upward momentum.
- Dividend and Fund Flow: Gevo does not currently pay dividends, which may be a concern for income-focused investors. Additionally, there has been a net fund outflow of $1.43 million, which could indicate investor caution or a shift in investor sentiment5.
|
---|
Silence TherapeuticsSLN |
TeslaTSLA |
GevoGEVO |
ChevronCVX |
View 4 results

- Price Target and Recent Performance: The average one-year price target for Gevo is $5.25, which is significantly lower than the current price6. This could suggest that the stock is overvalued based on its recent performance and analyst expectations.
In conclusion, while there is some analyst optimism about Gevo's potential, the poor financial performance, lack of dividends, and negative fund flow suggest that the stock is not a good buy at this time. Investors should exercise caution and consider these factors before making a decision.